CH, L., MJ, H., SH, C., KC, H., CJ, W., MY, H., . . . SJ, L. (2019). Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]. Dove Medical Press.
Chicago Style (17th ed.) CitationCH, Lee, et al. Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]. Dove Medical Press, 2019.
MLA (8th ed.) CitationCH, Lee, et al. Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.